MLT has been shown to provide a potential antiangiogenic effect to suppress vascular endothelial growth factor (VEGF)-induced tumor growth by blocking vascular endothelial growth factor receptor-2 (VEGFR-2) and the cyclooxygenase-2 (COX-2)-mediated mitogen-activated protein kinase (MAPK) signaling pathways [30]. The gene discussed is PTGS2; the disease is neoplasm.